Fedyk, Eric R.
38  results:
Search for persons X
?
 
?
2

Safety, tolerability, pharmacokinetics and pharmacodynamics..:

Fedyk, Eric R. ; Zhao, Lin ; Koch, Annelize...
British Journal of Clinical Pharmacology.  86 (2020)  7 - p. 1314-1325 , 2020
 
?
3

Pharmacokinetics and pharmacodynamics of the cytolytic anti..:

Roepcke, Stefan ; Plock, Nele ; Yuan, Josh...
Pharmacology Research & Perspectives.  6 (2018)  3 - p. , 2018
 
?
4

Exclusive antagonism of the α4β7 integrin by vedolizumab co..:

Fedyk, Eric R. ; Wyant, Tim ; Yang, Li-Li...
Inflammatory Bowel Diseases.  18 (2012)  11 - p. 2107-2119 , 2012
 
?
6

Pharmacological characterization of guinea pig chemoattract..:

Liu, Fang ; Gonzalo, Jose Angel ; Manning, Stephen...
Prostaglandins & Other Lipid Mediators.  76 (2005)  1-4 - p. 133-147 , 2005
 
?
 
?
8

Regulation of IgE and Cytokine Production by cAMP: Implicat..:

Fedyk, Eric R. ; Adawi, Adnan ; Looney, R.John.
Clinical Immunology and Immunopathology.  81 (1996)  2 - p. 101-113 , 1996
 
?
10

Prostaglandin E$_{2}$ Receptors of the EP$_{2}$ and EP$_{4}..:

Fedyk, Eric R. ; Phipps, Richard P.
Proceedings of the National Academy of Sciences of the United States of America.  93 (1996)  20 - p. 10978-10983 , 1996
 
?
11

Reactive oxygen species and not lipoxygenase products are r..:

Fedyk, Eric R. ; Phipps, Richard P.
International Journal of Immunopharmacology.  16 (1994)  7 - p. 533-546 , 1994
 
?
 
?
 
?
15

Antagonizing the alpha(4)beta(1) Integrin, but Not alpha(4)..:

Haanstra, Krista G ; Hofman, Sam O ; Estevao, Dave M. Lopes...
https://research.rug.nl/en/publications/c02caf9c-c7d7-4b85-80cc-496c537c2dd1.  , 2013
 
1-15